Hikal Ltd

BSE: 524735

23

total announcements

524735.BO · 15 min delayed

BSEOthersResults31 Aug 2026

Hikal Ltd

Annual Report for the financial year 2025-26

Hikal Ltd has released its Annual Report for the financial year 2025-26, highlighting progress in business performance, brand evolution, ESG, and cultural priorities. The company has strengthened its capabilities, expanded its CDMO pipeline, and operationalised its High-Potency API laboratory.

Read more →📎 1 attachment
BSEAGM/EGMResults31 Aug 2026

Hikal Ltd

Notice of the 38th Annual General Meeting of the Company

Hikal Ltd has issued a notice for its 38th Annual General Meeting (AGM) to be held on September 23, 2026, through video conferencing. The meeting will consider and adopt the audited standalone and consolidated financial statements for the financial year ended March 31, 2026, along with the reports of the Board of Directors and Auditors. The meeting will also consider the appointment of Mr. Sameer Hiremath as Chairman and Managing Director for a period of 5 years, commencing October 1, 2026, and approve his remuneration.

Read more →📎 1 attachment
BSECompany UpdateDividend27 Aug 2026

Hikal Ltd

Kindly find communication shared with shareholders.

Hikal Ltd has announced that the Board of Directors has recommended a Final Dividend of Rs. 0.40/- paise per equity share for the Financial Year ended March 31, 2026. The dividend will be payable post approval of the shareholders at the ensuing 38th Annual General Meeting (AGM) of the Company to be held on September 23, 2026. The Company will deduct tax at source (TDS) at the time of making the payment of the said Dividend if approved at the aforesaid AGM.

Read more →📎 1 attachment
BSECompany UpdateMgmt Change26 Aug 2026

Hikal Ltd

Please find attached intimation on appointment of Chairman and Managing Director of the Company, subject to approval of shareholders at ensuing AGM of the Company.

Hikal Ltd has announced the appointment of Mr. Sameer Hiremath as Chairman and Managing Director of the Company, subject to approval of shareholders at the ensuing AGM. Mr. Hiremath has been associated with Hikal for almost three decades and brings deep institutional knowledge and strong business acumen.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults12 Aug 2026

Hikal Ltd

Transcript of Earnings Conference Call for the quarter ended June 30, 2026

Hikal Ltd reported Q1 FY27 earnings, with revenue of Rs 403 crores and an EBITDA margin of 9.2%. The company's Pharmaceutical business delivered year-on-year growth despite a planned shutdown for U.S. FDA remediation efforts. Hikal has been awarded the EcoVadis Gold Medal Rating for sustainable performance.

Read more →📎 1 attachment
BSECompany UpdateResults7 Aug 2026

Hikal Ltd

Newspaper publication for Financial Results of Q1''FY27

Hikal Ltd has announced the newspaper publication of its unaudited financial results for Q1 FY27. The results have been posted on the company's website at pghealthindia.com. The company's registrar and transfer agent, MUFG Intime India Private Limited, will facilitate the re-lodgement of transfer requests of physical shares.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults6 Aug 2026

Hikal Ltd

Press Release on Q1FY27 Results

Hikal Ltd. announced its unaudited financial results for Q1FY27, with revenue at Rs. 403 Crs, EBITDA margin expanding 260 bps YoY, and PAT at Rs. (7) Crs. The company's pharmaceutical business delivered revenue of Rs. 233 Cr in Q1FY27, growth of 15.2% YoY, while the crop protection business witnessed improved domestic demand in the Own Products segment.

Read more →📎 1 attachment
BSECompany UpdateResults6 Aug 2026

Hikal Ltd

Investor Presentation for Q1FY27

Hikal Ltd has released its Q1FY27 investor presentation, highlighting a slower start to the year due to regulatory disruptions, but expressing confidence in its CDMO pipeline and specialty APIs. The company reported revenue of ₹403 Cr. with an EBITDA margin of 9.2%. It has also received a Gold rating from EcoVadis, placing it in the top 5% of companies globally.

Read more →📎 1 attachment
BSEBoard MeetingResults6 Aug 2026

Hikal Ltd

Outcome of Board Meeting pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Hikal Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, and has also disclosed that the trading window for designated persons will re-open on August 09, 2026. The company's board of directors has approved the financial results, which have been reviewed by the independent auditor. The auditor's review report highlights that nothing has come to their attention that causes them to believe that the financial results contain any material misstatement. However, the auditor draws attention to a note in the financial results regarding uncertainty regarding the outcome of investigations/actions by statutory authorities in relation to alleged non-compliance with certain environmental laws and regulations.

Read more →📎 1 attachment
BSEResultResults6 Aug 2026

Hikal Ltd

Unaudited Financial Results (Standalone & Consolidated) for Quarter ended June 30, 2026.

Hikal Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with the Board of Directors approving the results at a meeting held on August 6, 2026. The trading window for designated persons will reopen on August 9, 2026. The company's auditor has issued a limited review report, expressing no material misstatement in the financial results. However, the report draws attention to a pending matter regarding alleged non-compliance with environmental laws and regulations, currently under investigation by the Supreme Court of India.

Read more →📎 1 attachment
Page 1 of 2Next →